Form DEL AM NANOVIRICIDES, INC.

 

 

  

December 16, 2025

 

Via EDGAR

 

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

 

 

	Re:	NanoViricides, Inc
		Registration Statement on Form S-3
		(File No. 333-292142) filed on December 15, 2025

 

To Whom It May Concern:

 

Reference is made to the Registration Statement on Form S-3 (File No. 333-292142) filed by NanoViricides, Inc. (the “Issuer”) on December 15, 2025 (the “Registration Statement”).

 

Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the “Act”), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated onto the facing page of the Registration Statement:

 

“The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this registration statement shall become effective on such date as the SEC, acting pursuant to said Section 8(a) may determine.”

 

Should you have any questions regarding the Registration Statement, please feel free to contact Peter Campitiello, counsel to the Issuer at (732) 395-4517.

  

 

Very truly yours,

 

/s/ Anil Diwan

Chairman, President

NanoViricides, Inc.

  

 

cc: Peter Campitiello, Esq. 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tradr to Ring Opening Bell at Cboe to Celebrate SpaceX ETF Launches
• Growing Consumer Interest in Natural Supplements for Thyroid Health Leads PureHealth Research to Highlight Iodine, Selenium, and Ashwagandha
• Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL